Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?

We presented a letter about a case of a 37-year-old Black female with a history of human immunodeficiency virus and an undetectable viral load. She was evaluated with weakness in the scapular (grade III) and pelvic girdles (grade II), elevation of creatine phosphokinase levels and muscle biopsy comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonçalves Júnior, Jucier, Shinjo, Samuel Katsuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855173/
https://www.ncbi.nlm.nih.gov/pubmed/35211583
http://dx.doi.org/10.12998/wjcc.v10.i4.1454
_version_ 1784653597735124992
author Gonçalves Júnior, Jucier
Shinjo, Samuel Katsuyuki
author_facet Gonçalves Júnior, Jucier
Shinjo, Samuel Katsuyuki
author_sort Gonçalves Júnior, Jucier
collection PubMed
description We presented a letter about a case of a 37-year-old Black female with a history of human immunodeficiency virus and an undetectable viral load. She was evaluated with weakness in the scapular (grade III) and pelvic girdles (grade II), elevation of creatine phosphokinase levels and muscle biopsy compatible with nemaline myopathy. She was treated with rituximab showing improvement of the condition.
format Online
Article
Text
id pubmed-8855173
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-88551732022-02-23 Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us? Gonçalves Júnior, Jucier Shinjo, Samuel Katsuyuki World J Clin Cases Letter to the Editor We presented a letter about a case of a 37-year-old Black female with a history of human immunodeficiency virus and an undetectable viral load. She was evaluated with weakness in the scapular (grade III) and pelvic girdles (grade II), elevation of creatine phosphokinase levels and muscle biopsy compatible with nemaline myopathy. She was treated with rituximab showing improvement of the condition. Baishideng Publishing Group Inc 2022-02-06 2022-02-06 /pmc/articles/PMC8855173/ /pubmed/35211583 http://dx.doi.org/10.12998/wjcc.v10.i4.1454 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Letter to the Editor
Gonçalves Júnior, Jucier
Shinjo, Samuel Katsuyuki
Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
title Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
title_full Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
title_fullStr Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
title_full_unstemmed Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
title_short Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
title_sort rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: what does the literature have to tell us?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855173/
https://www.ncbi.nlm.nih.gov/pubmed/35211583
http://dx.doi.org/10.12998/wjcc.v10.i4.1454
work_keys_str_mv AT goncalvesjuniorjucier rituximabasatreatmentforhumanimmunodeficiencyvirusassociatednemalinemyopathywhatdoestheliteraturehavetotellus
AT shinjosamuelkatsuyuki rituximabasatreatmentforhumanimmunodeficiencyvirusassociatednemalinemyopathywhatdoestheliteraturehavetotellus

Ejemplares similares